EUVIMEDEUVIMED entdecken
Open Access

The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of C-MYC

Yusuke Aoki, Yutaro Kubota, Qinghong Han, Noriyuki Masaki, Koya Obara, Michael Bouvet, Sant P Chawla, Yasunori Tome, Kotaro Nishida, Robert M Hoffman

Cancer Genomics - Proteomics · 2023

DOI: 10.21873/cgp.20415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2023. Verfasst von Yusuke Aoki und 9 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc, San Diego, CA, U.S.A.; yaoki0630@gmail.com. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsOsteosarcomaHumansEthionineMethionineRacemethionineRecombinant ProteinsCarbon-Sulfur Lyases

Stichwörter der Autor:innen

Hoffman effectMethioninasec-MYCdown-regulationeradicationethioninemethionine addictionosteosarcomasynergy

Substanzen

EthionineMethionineRacemethionineRecombinant ProteinsL-methionine gamma-lyaseCarbon-Sulfur Lyases

Autor:innen und Institutionen

  • AntiCancer Inc, San Diego, CA, U.S.A.; yaoki0630@gmail.com.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • AntiCancer Inc, San Diego, CA, U.S.A.
  • Sarcoma Oncology Center, Santa Monica, CA, U.S.A.
  • Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; yastome@med.u-ryukyu.ac.jp.

Zitieren

APA

Aoki, Y., Kubota, Y., Han, Q., Masaki, N., Obara, K., Bouvet, M., Chawla, S. P., Tome, Y., Nishida, K., & Hoffman, R. M. (2023). The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of C-MYC. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20415

Vancouver

Aoki Y, Kubota Y, Han Q, Masaki N, Obara K, Bouvet M, et al. The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of C-MYC. Cancer Genomics - Proteomics. 2023. doi:10.21873/cgp.20415

BibTeX
@article{Aoki2023,
  author = {Aoki, Yusuke and Kubota, Yutaro and Han, Qinghong and Masaki, Noriyuki and Obara, Koya and Bouvet, Michael and Chawla, Sant P and Tome, Yasunori and Nishida, Kotaro and Hoffman, Robert M},
  title = {The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of C-MYC},
  journal = {Cancer Genomics - Proteomics},
  year = {2023},
  doi = {10.21873/cgp.20415}
}
Kostenlos starten →